Author:
Bogaerts Jan,Cardoso Fatima,Buyse Marc,Braga Sofia,Loi Sherene,Harrison Jillian A,Bines Jacques,Mook Stella,Decker Nuria,Ravdin Peter,Therasse Patrick,Rutgers Emiel,van 't Veer Laura J,Piccart Martine
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Reference28 articles.
1. van de Vijver MJ et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Eng J Med 447: 1999–2009
2. Hutchins L et al. (1998) CMF versus CAF with and without Tamoxifen in high-risk node-negative breast cancer patients and a natural history follow-up study in low-risk node-negative patients: First results of Intergroup trial INT 0102 [abstract #2]. Proc Am Soc Clin Oncol 17: a1
3. McShane LM et al. (2005) REporting recommendations for tumour MARKer prognostic studies. Nat Clin Pract Oncol 2: 416–422
4. [No authors listed] (2001) The National Institutes of Health Consensus Development Conference: adjuvant therapy for breast cancer. Bethesda, Maryland, USA. November 1–3, 2000. Proceedings. J Natl Cancer Inst Monogr 30: 1–152
5. Goldhirsch A et al. (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16: 1569–1583
Cited by
202 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献